A detailed history of Vantage Financial Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Vantage Financial Partners, LLC holds 2,350 shares of JNJ stock, worth $364,649. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,350
Previous 2,017 16.51%
Holding current value
$364,649
Previous $294,000 29.25%
% of portfolio
0.1%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$145.48 - $167.38 $48,444 - $55,737
333 Added 16.51%
2,350 $380,000
Q2 2024

Aug 07, 2024

BUY
$144.38 - $157.78 $84,751 - $92,616
587 Added 41.05%
2,017 $294,000
Q1 2024

May 02, 2024

BUY
$155.22 - $162.74 $5,898 - $6,184
38 Added 2.73%
1,430 $226,000
Q4 2023

Feb 05, 2024

BUY
$145.6 - $158.88 $202,675 - $221,160
1,392 New
1,392 $218,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Vantage Financial Partners, LLC Portfolio

Follow Vantage Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Financial Partners, LLC with notifications on news.